NASDAQ:MLAB - Mesa Laboratories Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $273.50
  • Forecasted Upside: 0.58 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$271.91
▼ -4.1 (-1.49%)
1 month | 3 months | 12 months
Get New Mesa Laboratories Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MLAB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MLAB

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$273.50
▲ +0.58% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Mesa Laboratories in the last 3 months. The average price target is $273.50, with a high forecast of $287.00 and a low forecast of $260.00. The average price target represents a 0.58% upside from the last price of $271.91.
Hold
The current consensus among 2 contributing investment analysts is to hold stock in Mesa Laboratories. This rating has held steady since October 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/7/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/6/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/5/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/3/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/1/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/28/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/9/2020KeyCorpInitiated CoverageSector Weight ➝ Sector Weight$287.00High
i
10/2/2020JPMorgan Chase & Co.Initiated CoverageNeutral$260.00Low
i
12/4/2019Jefferies Financial GroupInitiated CoverageBuy$275.00 ➝ $275.00High
i
8/26/2019Evercore ISIInitiated CoverageOutperform$250.00High
i
3/13/2019SidotiInitiated CoverageNeutralHigh
i
12/23/2016Janney Montgomery ScottReiterated RatingBuyN/A
i
6/10/2016SidotiDowngradeBuy ➝ Neutral$132.00N/A
i
(Data available from 2/28/2016 forward)
Mesa Laboratories logo
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Canada, Europe, and Japan. The company's Sterilization and Disinfection Control segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and offers testing services. This segment also provides chemical and cleaning indicators that are used to assess the effectiveness of sterilization and cleaning processes. Its Instruments segment offers data loggers used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air sampling; and torque testing systems used for measure bottle cap tightness. This segment's products are used in healthcare, pharmaceutical, medical device, food and beverage, industrial hygiene, and environmental air sampling industries. The company's Biopharmaceutical Development segment develops, manufactures, and commercializes automated solutions for protein analysis, which include analysis equipment, CDs, kits, and buffers; and peptide synthesizers to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. Its Continuous Monitoring segment offers systems, which are used to monitor temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was founded in 1982 and is headquartered in Lakewood, Colorado.
Read More

Today's Range

Now: $271.91
$269.92
$277.28

50 Day Range

MA: $285.59
$274.67
$297.01

52 Week Range

Now: $271.91
$181.90
$307.97

Volume

22,064 shs

Average Volume

23,623 shs

Market Capitalization

$1.40 billion

P/E Ratio

N/A

Dividend Yield

0.23%

Beta

0.39

Frequently Asked Questions

What sell-side analysts currently cover shares of Mesa Laboratories?

The following sell-side analysts have issued research reports on Mesa Laboratories in the last twelve months: JPMorgan Chase & Co., KeyCorp, and Zacks Investment Research.
View the latest analyst ratings for MLAB.

What is the current price target for Mesa Laboratories?

2 Wall Street analysts have set twelve-month price targets for Mesa Laboratories in the last year. Their average twelve-month price target is $273.50, suggesting a possible upside of 0.6%. KeyCorp has the highest price target set, predicting MLAB will reach $287.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $260.00 for Mesa Laboratories in the next year.
View the latest price targets for MLAB.

What is the current consensus analyst rating for Mesa Laboratories?

Mesa Laboratories currently has 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MLAB, but not buy more shares or sell existing shares.
View the latest ratings for MLAB.

What other companies compete with Mesa Laboratories?

How do I contact Mesa Laboratories' investor relations team?

Mesa Laboratories' physical mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier's listed phone number is 303-987-8000 and its investor relations email address is [email protected] The official website for Mesa Laboratories is www.mesalabs.com.